50.021445, 19.887845
PDF / print export
Ryvu Therapeutics
Krakow, Poland
- Verified lead
- Pawel Przewiezlikowski
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and President of the Management Board
- 2026 technical specialization
- Oncology Small-Molecule Therapeutics
- Review cycle
- May 2026
- Full address
- Leona Henryka Sternbacha 2, 30-394 Kraków, Poland
- Site coordinates
- 50.021445, 19.887845
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Ryvu corporate page used for executive verification.
- Editorial note
- Clinical-stage discovery campus with oncology screening platforms, translational biology, and medicinal chemistry execution for partnered development.
Oncology Small-Molecule Therapeutics
Clinical-stage biopharma platform
Clinical-stage discovery campus with oncology screening platforms, translational biology, and medicinal chemistry execution for partnered development.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Krakow, Poland
Ryvu Therapeutics
Oncology Small-Molecule Therapeutics · Clinical-stage drug discovery
Clinical-stage discovery campus with oncology screening platforms, translational biology, and medicinal chemistry execution for partnered development.
- Lead
- Pawel Przewiezlikowski (verified ↗)
- Address
- Leona Henryka Sternbacha 2, 30-394 Kraków, Poland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Clinical-stage drug discovery
- Capabilities
- Oncology Drug Discovery · Clinical Development · Translational Biology
- Founded
- 2007
- Headcount
- 201-500
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Pawel Przewiezlikowski
Chief Executive Officer and President of the Management Board
Full addressLeona Henryka Sternbacha 2, 30-394 Kraków, Poland
Site coordinates50.021445, 19.887845
Review cycleMay 2026
Physical site source
Official Ryvu contact page listing Leona Henryka Sternbacha 2, Kraków.
Open sourceClinical-stage drug discovery
Krakow, Poland. Oncology Small-Molecule Therapeutics. Review completed on 14 Mar 2026.
Polish and EU medicinal product oversight
Clinical-stage biopharma platform
Oncology Small-Molecule Therapeutics
Clinical-stage discovery campus with oncology screening platforms, translational biology, and medicinal chemistry execution for partnered development.
Editorial note
Ryvu is published as a Polish oncology-discovery anchor with clear relevance to related German therapeutic and platform companies.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Oncology Drug Discovery
Clinical Development
Translational Biology
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Medicinal chemistry laboratories
Preclinical screening platforms
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Ryvu Therapeutics located?
- Ryvu Therapeutics operates from Leona Henryka Sternbacha 2, 30-394 Kraków, Poland, Krakow, Poland.
- Who runs Ryvu Therapeutics?
- Ryvu Therapeutics is led by Pawel Przewiezlikowski, Chief Executive Officer and President of the Management Board. Verified 14 Mar 2026.
- What does Ryvu Therapeutics do?
- Clinical-stage discovery campus with oncology screening platforms, translational biology, and medicinal chemistry execution for partnered development. Core capabilities: Oncology Drug Discovery, Clinical Development, Translational Biology.
Editorial context
Related technical briefs
Briefs that name Krakow as a covered market or city.